Home
NICE Guidance
Conditions and diseases
Gynaecological conditions
Heavy menstrual bleeding
Heavy menstrual bleeding
Explore
Register as a stakeholder
Show sections
Research Recommendations
NICE encourages further research into the effects of uterine artery embolisation compared with other procedures to treat aden...
December 2013
Do not do
Measuring menstrual blood loss either directly (alkaline haematin) or indirectly ('Pictorial blood loss assessment chart') is not routinely recommended for HMB. Whether menstrual blood loss is a problem should be determined not by measuring blood loss but by the woman herself. [2007]
December 2016
A serum ferritin test should not routinely be carried out on women with HMB. [2007]
December 2016
Female hormone testing should not be carried out on women with HMB. [2007]
December 2016
Saline infusion sonography should not be used as a first-line diagnostic tool.
December 2016
Magnetic resonance imaging (MRI) should not be used as a first-line diagnostic tool. [2007]
December 2016
Dilatation and curettage alone should not be used as a diagnostic tool. [2007]
December 2016
Use of NSAIDs and/or tranexamic acid should be stopped if it does not improve symptoms within 3 menstrual cycles. [2007]
December 2016
Danazol should not be used routinely for the treatment of HMB. [2007]
December 2016
Oral progestogens given during the luteal phase only should not be used for the treatment of HMB. [2007]
December 2016
Etamsylate should not be used for the treatment of HMB. [2007]
December 2016
Full List
Guidance
Resources
Savings and productivity